News & Events

News

NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project

30 Jun '22

Press Release

Domainex appoints Dr Scott Martin as Analytical and Bioanalytical Group Leader

12 May '22

Press Release

Domainex expands analytical chemistry capabilities with over £1M worth of new Waters equipment

3 Mar '22

Press Release

Domainex opens a dedicated new facility at Unity Campus to expand research operations

10 Feb '22

Press Release

Parkinson’s UK and Domainex collaborate to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s

3 Feb '22

Press Release

Articles

Meet the Domainex Team: Cameron Haddow

11 Aug '22

Blog Post

Synthesis in Review: New synthetic methods to access stereogenic-at-P(V) compounds and trifluoromethylated analogues

10 Aug '22

Blog Post

Medicinal Chemistry in Review: Metabolic hydrolysis of heteroaryl/aryl sulfonamides; a potential toxicological flag

8 Aug '22

Blog Post

Medicinal Chemistry in Review: Clesacostat — Exploiting hepatic uptake for asymmetric tissue distribution

26 Jul '22

Blog Post

Synthesis in Review: Useful and versatile synthetic methods involving the deoxygenation of alcohols

12 Jul '22

Blog Post

Meet the Domainex Team: Nima Abbasian

14 Jun '22

Blog Post

Events

Sep 4 XXVll EFMC International Symposium on Medicinal Chemistry

Sep 12 Chemical Biology meets Drug Discovery

Oct 5 17th Drug Discovery Innovation Programme

Oct 6 14th Annual Healthcare Investor Conference

Oct 17 Discovery on Target

Tweets

Tweets by Domainex_UK

News & Events

News

Domainex appoints Eddy Littler as Executive Chairman

NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project

Domainex appoints Dr Scott Martin as Analytical and Bioanalytical Group Leader

Domainex expands analytical chemistry capabilities with over £1M worth of new Waters equipment

Domainex opens a dedicated new facility at Unity Campus to expand research operations

Parkinson’s UK and Domainex collaborate to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s

Articles

Meet the Domainex Team: Cameron Haddow

Synthesis in Review: New synthetic methods to access stereogenic-at-P(V) compounds and trifluoromethylated analogues

Medicinal Chemistry in Review: Metabolic hydrolysis of heteroaryl/aryl sulfonamides; a potential toxicological flag

Medicinal Chemistry in Review: Clesacostat — Exploiting hepatic uptake for asymmetric tissue distribution

Synthesis in Review: Useful and versatile synthetic methods involving the deoxygenation of alcohols

Meet the Domainex Team: Nima Abbasian

Events

Sep 4 XXVll EFMC International Symposium on Medicinal Chemistry

Sep 12 Chemical Biology meets Drug Discovery

Oct 5 17th Drug Discovery Innovation Programme

Oct 6 14th Annual Healthcare Investor Conference

Oct 17 Discovery on Target

Tweets

Offerings

Research Phases

Therapeutic Areas

Target Classes

Approaches & Techniques